Indoco Remedies Limited

Indoco Remedies Limited

Aktie · INE873D01024 (XBOM)
Übersicht
AI-gestützte Analyse
Fundamental-Analyse
Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.
Jetzt analysieren
News Sentiment
Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.
Jetzt analysieren
Kaufen / Halten / Verkaufen
Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.
Jetzt analysieren
Risiko-Bewertung
Risiken erkennen, bevor sie zum Problem werden.
Jetzt analysieren
Fair Value
Zu teuer, fair bewertet oder ein Schnäppchen?
Jetzt analysieren
Neuste KI Analysen zu Indoco Remedies Limited
Kein Kurs
Schlusskurs XBOM 29.04.2026: 210,00 INR
29.04.2026 09:59
Aktuelle Kurse von Indoco Remedies Limited
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNSE: NSE
NSE
INDOCO.NS
INR
29.04.2026 09:59
209,51 INR
-2,09 INR
-0,99 %
XBOM: MSE
MSE
INDOCO.BO
INR
29.04.2026 09:51
210,00 INR
-1,60 INR
-0,76 %
Free Float & Liquidität
Free Float 39,35 %
Shares Float 36,26 M
Ausstehende Aktien 92,16 M
Firmenprofil zu Indoco Remedies Limited Aktie
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Unternehmensdaten

Name Indoco Remedies Limited
Firma Indoco Remedies Limited
Website https://www.indoco.com
Heimatbörse XBOM MSE
ISIN INE873D01024
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Suresh Govind Kare
Marktkapitalisierung 20 Mrd.
Land Indien
Währung INR
Mitarbeiter 6,0 T
Adresse Indoco House, 400098 Mumbai
IPO Datum 2005-01-14
Dividenden von 'Indoco Remedies Limited'
Ex-Datum Dividende pro Aktie
04.09.2025 0,20 INR
19.09.2024 1,50 INR
18.09.2023 2,25 INR
14.09.2022 2,25 INR
17.09.2021 1,50 INR
18.09.2020 0,30 INR
22.08.2019 0,30 INR
31.08.2018 1,00 INR
31.07.2017 1,60 INR
20.07.2016 0,20 INR

Aktien-Splits

Datum Split
17.05.2012 15:2

Ticker Symbole

Name Symbol
MSE INDOCO.BO
NSE INDOCO.NS
Weitere Aktien
Investoren, die Indoco Remedies Limited halten, haben auch folgende Aktien im Depot:
BL Fund Selection 0-50 Actions Nominatives B o.N.
BL Fund Selection 0-50 Actions Nominatives B o.N. Unbekannt
ORACLE 20/30
ORACLE 20/30 Anleihe